<DOC>
	<DOCNO>NCT00302991</DOCNO>
	<brief_summary>Observational , multicentre , epidemiological study determine HRQOL patient epilepsy accord treatment sub-group validate Spanish version Adverse Events Profile , produce G. Baker et al . Three treatment group examine : patient receive new anti-epilepsy drug ( AED ) , patient receive `` classic '' AED ; patient receive combination therapy .</brief_summary>
	<brief_title>Quality Life Adverse Effects Epilepsy Patients ( EPIKA )</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<criteria>Epileptic adult patient treat stable dose one AEDs ≥ 3 month Symptomatic epilepsy due malignant brain tumour progressive brain disease . Confirmed diagnosis concomitant chronic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Observational</keyword>
	<keyword>cross-sectional</keyword>
	<keyword>health-related quality life</keyword>
	<keyword>adverse effect</keyword>
	<keyword>Baker´s AEP scale validation</keyword>
	<keyword>epilepsy</keyword>
</DOC>